Live feed08:00:00·12dPRReleasevia QuantisnowEupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis PatientsByQuantisnow·Wall Street's wire, on your screen.EPRX· Eupraxia Pharmaceuticals Inc.Health Care
